Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Apr 17, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Notice of Fiscal Policies in Effect for FY 2022
(NOT-OD-22-105)
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar for Companion Announcements RFA-AG-23-012, RFA-AG-23-013, and RFA-AG-23-015 on The Aging Hallmarks
(NOT-AG-22-021)
National Institute on Aging
- Notice of Early Termination of PAR-20-294, Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
(NOT-CA-22-080)
National Cancer Institute
- Notice of Informational Webinar on NIGMS Technology Development Program Funding Opportunity Announcements (PAR 22-126 and PAR 22-127)
(NOT-GM-22-034)
National Institute of General Medical Sciences
- Notice of Informational Webinar for PAR-20-296, "Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed)"
(NOT-GM-22-035)
National Institute of General Medical Sciences
- Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2022
(NOT-OD-22-108)
Office of the Director, NIH
Agency for Healthcare Research and Quality
- Notice of Correction to RFA-OD-22-011: Clarification on Number of Applications an Organization Can Submit
(NOT-OD-22-111)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of NIDA's Participation in PAR-21-277, " Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
(NOT-DA-22-057)
National Institute on Drug Abuse
- Notice of Change to Key Dates for PAR-21-264,"Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)"
(NOT-MH-22-230)
National Institute of Mental Health
- Notice to Extend the Response Date for NOT-NS-22-044 "BRAIN Initiative: Request for Information (RFI) on Industry Collaboration in Development and Dissemination of Non-Invasive Brain Imaging Technologies"
(NOT-NS-22-093)
National Institute of Neurological Disorders and Stroke
National Institute of Biomedical Imaging and Bioengineering
National Institute of Mental Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
(NOT-DE-22-008)
National Institute of Dental and Craniofacial Research
- Notice of Intent to Publish a Funding Opportunity Announcement for Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
(NOT-NS-22-094)
National Institute of Neurological Disorders and Stroke
- Notice of Intent to Publish a Funding Opportunity Announcement for Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
(NOT-NS-22-096)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notices of Special Interest (NOSI): High Priority Areas in Genetics, Epigenetics, and Developmental Neuroscience Branch in the Division of Neuroscience and Behavior
(NOT-DA-23-004)
National Institute on Drug Abuse
Funding Opportunities
- AHRQ Administrative Supplements for Grants in Health Services Research
(PA-22-168)
Agency for Healthcare Research and Quality
- Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
(PAR-22-131)
National Cancer Institute
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
(PAR-22-136)
National Cancer Institute
- NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
(PAR-22-149)
National Eye Institute
- Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
(PAR-22-162)
National Cancer Institute
- Specialized Alcohol Research Centers (P50 Clinical trial Optional)
(RFA-AA-22-001)
National Institute on Alcohol Abuse and Alcoholism
- Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
(RFA-AA-22-002)
National Institute on Alcohol Abuse and Alcoholism
- Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
(RFA-AG-23-016)
National Institute on Aging
- Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)
(RFA-AI-22-024)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
- Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
(RFA-MD-22-009)
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health
- Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
(RFA-RM-22-014)
Office of Strategic Coordination (Common Fund)
- IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
(RFA-RM-22-015)
Office of Strategic Coordination (Common Fund)
- Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)
(RFA-RM-22-016)
Office of Strategic Coordination (Common Fund)
- Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed)
(RFA-RM-22-017)
Office of Strategic Coordination (Common Fund)
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-22-018)
Office of Strategic Coordination (Common Fund)
- Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
(RFA-RM-22-024)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).